MOMETASONE FUROATE MONOHYDRATE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mometasone furoate monohydrate

intervet australia pty limited - mometasone furoate monohydrate - unknown - mometasone furoate monohydrate adrenocorticoid-synthetic active 0.0 - active constituent

MOMASONE mometasone furoate 1mg/g ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

momasone mometasone furoate 1mg/g ointment tube

aspen pharma pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: white soft paraffin; hexylene glycol; white beeswax; purified water; propylene glycol monostearate; phosphoric acid - indicated for short-term (up to four continuous weeks) relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis & atopic dermatitis.

MOMASONE mometasone furoate 0.1% w/w lotion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

momasone mometasone furoate 0.1% w/w lotion bottle

medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: monobasic sodium phosphate; phosphoric acid; propylene glycol; hyprolose; isopropyl alcohol; purified water - short-term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis. the lotion is also suitable for short-term use for scalp psoriasis and seborrhoeic dermatitis.

NOVASONE mometasone furoate 1 mg/g cream tube Australia - English - Department of Health (Therapeutic Goods Administration)

novasone mometasone furoate 1 mg/g cream tube

organon pharma pty ltd - mometasone furoate, quantity: 1 mg/g - cream - excipient ingredients: aluminium starch octenylsuccinate; white soft paraffin; titanium dioxide; phosphoric acid; purified water; white beeswax; hexylene glycol; hydrogenated soy phosphatidylcholine - novasone cream, ointment and lotion are indicated for short-term (up to four (4) continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis and atopic dermatitis. novasone lotion is also suitable for short-term use for scalp psoriasis and seborrhoeic dermatitis.

ELOCON ALCOHOL FREE mometasone furoate 1mg/g cream Australia - English - Department of Health (Therapeutic Goods Administration)

elocon alcohol free mometasone furoate 1mg/g cream

organon pharma pty ltd - mometasone furoate, quantity: 1 mg/g - cream - excipient ingredients: hexylene glycol; white beeswax; purified water; aluminium starch octenylsuccinate; phosphoric acid; titanium dioxide; white soft paraffin; hydrogenated soy phosphatidylcholine - elocon alcohol free cream ointment and lotion are indicated for short-term up to four (4) continuous weeks relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis and atopic dermatitis. elocon lotion is also suitable for short-term use for scalp psoriasis and seborrhoeic dermatitis.

UNICLAR AQUEOUS NASAL SPRAY 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol Australia - English - Department of Health (Therapeutic Goods Administration)

uniclar aqueous nasal spray 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol

organon pharma pty ltd - mometasone furoate, quantity: 50 microgram/actuation - spray, suspension - excipient ingredients: benzalkonium chloride; citric acid monohydrate; sodium citrate dihydrate; dispersible cellulose; glycerol; citric acid; polysorbate 80; purified water - uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis in adults, adolescents and children between the ages of 3 and 11 years. uniclar aqueous nasal spray 0.05% is also indicated for the treatment of nasal polyps in adult patients 18 years of age and older. uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without signs or symptoms of severe bacterial infection.

MOMETASONE FUROATE spray metered United States - English - NLM (National Library of Medicine)

mometasone furoate spray metered

avkare, inc. - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate 50 ug

MOMASONE mometasone furoate 0.1% w/w cream tube Australia - English - Department of Health (Therapeutic Goods Administration)

momasone mometasone furoate 0.1% w/w cream tube

medis pharma pty ltd - mometasone furoate -

MOMETASONE FUROATE ointment United States - English - NLM (National Library of Medicine)

mometasone furoate ointment

harris pharmaceutical, inc. - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate 1 mg in 1 g

ZATAMIL 0.1% OINTMENT mometasone furoate 0.1% w/w (1 mg/g) ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

zatamil 0.1% ointment mometasone furoate 0.1% w/w (1 mg/g) ointment tube

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: hexylene glycol; citric acid; light liquid paraffin; purified water; white soft paraffin; polyethylene; colloidal anhydrous silica; cetostearyl alcohol - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.